BRCA2 and Hereditary breast cancer: DNA sequencing performed by Myriad Genetic Laboratories on patient III: 22, who had lobular breast cancer, uncovered a BRCA2 exon 3 542G>T mutation, predicted to result in a truncated protein (L105X).